Further research shows that the test is accurate.
When it comes to genetic neurological and neuromuscular diseases, screening early is key to getting the right treatment. A new DNA test developed by researchers at the Garvan Institute of Medical Research in Sydney may help in this process, as reported by the institution in a press release published on Saturday.
Garvan researchers have shown how new genomic sequencing technology can reduce the ‘diagnostic odyssey’ experienced by people with rare neurological and neuromuscular diseases.